Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 127,212 shares at $27.82 ($3.6M) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Scheduled sale ($3.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.82 | 37,723 | $1.0M | 29.2% |
| 2 | $27.82 | 37,723 | $1.0M | 29.2% |
| 3 | $28.54 | 20,277 | $579K | 16.1% |
| 4 | $28.54 | 20,277 | $579K | 16.1% |
| 5 | $30.06 | 5,606 | $169K | 4.7% |
| 6 | $30.06 | 5,606 |
| $169K |
| 4.7% |
| Total | $28.25 avg | 127,212 | $3.6M | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |